The global pharmaceutical industry experienced an 11% rise in new job postings related to cloud in Q2 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 13% decrease versus Q2 2022. GlobalData’s Cloud Computing in Healthcare – Thematic Intelligence report offers a detailed understanding of how Cloud impacts the value chain in the Pharmaceutical sector. It includes market sizing analysis and the leading Cloud adopters and vendors in the market. Buy the report here.
Notably, Computer and Mathematical Occupations jobs accounted for a 43% share of the global pharmaceutical industry’s cloud-related total new job postings in Q2 2023, up 11% over the prior quarter.
Computer and Mathematical Occupations drive cloud-related hiring activity
Computer and Mathematical Occupations, with a share of 43%, emerged as the top cloud-related job roles within the pharmaceutical industry in Q2 2023, with new job postings rising by 11% quarter-on-quarter. Management Occupations came in second with a share of 24% in Q2 2023, with new job postings dropping by 6% over the previous quarter.
The other prominent cloud roles include Architecture and Engineering Occupations with a 3% share in Q2 2023, Business and Financial Operations Occupations with a 2% share of new job postings.
Top five companies in pharmaceutical industry accounted for 36% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2023 were Novartis, Novo Nordisk, Bristol-Myers Squibb, Merck, and Takeda Pharmaceutical. Together they accounted for a combined share of 36% of all cloud-related new jobs in the pharmaceutical industry.
Novartis posted 307 cloud-related new jobs in Q2 2023, Novo Nordisk 195 jobs, Bristol-Myers Squibb 181 jobs, Merck 159 jobs, and Takeda Pharmaceutical 141 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 39.88% share of total new job postings, Q2 2023
The largest share of cloud-related new job postings in the pharmaceutical industry in Q2 2023 was in the US with 39.88% followed by India (21.44%) and the Czech Republic (7.69%). The share represented by the US was 15 percentage points lower than the 54.82% share it accounted for in Q1 2023.
For further understanding of GlobalData's Cloud Computing in Healthcare – Thematic Intelligence, buy the report here.